Mon, Dec 22, 2014, 7:08 AM EST - U.S. Markets open in 2 hrs 22 mins

Recent

% | $
Quotes you view appear here for quick access.

Gilead Sciences Inc. Message Board

meshach60 3 posts  |  Last Activity: Dec 2, 2014 2:58 PM Member since: Mar 9, 2007
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    WALLOW

    by losesomewinsome Sep 18, 2014 6:44 PM
    meshach60 meshach60 Dec 2, 2014 2:58 PM Flag

    http://clinicaltrials.gov/ct2/show/record/NCT01044654 does not tell us when they will make any report on data collected. This study is ongoing, but not recruiting participants.

    Sentiment: Hold

  • Reply to

    sloppy patent dept

    by ray_crucet Nov 13, 2014 10:15 AM
    meshach60 meshach60 Nov 13, 2014 10:49 AM Flag

    Which patent law suit has Gilead's legal department lost?

  • meshach60 meshach60 Nov 7, 2014 11:01 AM Flag

    Humana said investments in ObamaCare health care exchanges and state-based contracts as well as increased costs related to a new hepatitis C treatment weighed down Q3 earnings.

    Read More At Investor's Business Daily: http://news.investors.com/business/110714-725466-humana-misses-higher-costs-narrows-eps-outlook.htm#ixzz3IOmoqjdq
    Follow us: @IBDinvestors on Twitter | InvestorsBusinessDaily on Facebook

    My take is that they want to blame Gilead instead of ObamaCare and state-based contracts for their weak Q3 data. It is easier to blame Gilead, with a better chance of changing that issue, than getting ObamaCare to be a profit for the company. just my take.

GILD
108.45-6.64(-6.12%)Dec 19 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.